Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SunLyte: Bitopertin for negative symptoms of schizophrenia
NCT01192880Phase 3Completed
- Sponsor
- Roche
- Start
- Nov 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of bitopertin in schizophrenia, sponsored by Roche. Started Nov 2010; status: completed.
02
Drugs
bitopertin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01192880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192880.